ITPRIP and hepatocellular carcinoma: Since the cyclin D1b has been shown to have enhanced oncogenic functions when compared with the full-length D1a, we considered whether the expression of cyclin D1b and cyclin D1a or the relative abundance of each variant were dysregulated in HBV-related HCC.